Key result
Epoprostenol administered pre-oxygenator successfully treated increased pressure drop and elevated pre-oxygenator blood pressure during cardiopulmonary bypass.
Why the study?
Does pre-oxygenator-administered epoprostenol improve increasing oxygenator pressure drop during cardiopulmonary bypass?
Population
A patient experiencing increased pressure drop and pre-oxygenator blood pressure during cardiopulmonary bypass
Design
Case_report
Authors
Loading...
May offer a rescue option for oxygenator pressure issues on CPB; leaves open need for prospective safety and efficacy data.
Does pre-oxygenator-administered epoprostenol improve increasing oxygenator pressure drop during cardiopulmonary bypass?
Epoprostenol administration may be a viable rescue strategy for increasing oxygenator pressure drop during cardiopulmonary bypass, potentially avoiding the high-risk procedure of oxygenator exchange.
Hjärpe et al. (2017) studied this question. Epoprostenol administered pre-oxygenator successfully treated increased pressure drop and elevated pre-oxygenator blood pressure during cardiopulmonary bypass.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: